Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.35 USD | -2.64% | -3.13% | +74.00% |
Strengths
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The opinion of analysts covering the stock has improved over the past four months.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- Low profitability weakens the company.
- With an enterprise value anticipated at 4.21 times the sales for the current fiscal year, the company turns out to be overvalued.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
- Over the past twelve months, analysts' opinions have been revised negatively.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+74.00% | 842M | C | ||
-7.38% | 177B | C+ | ||
-0.46% | 108B | C | ||
-6.98% | 65.55B | A | ||
+2.65% | 50.66B | B- | ||
+5.27% | 42.58B | B- | ||
+5.73% | 40.74B | B+ | ||
+19.92% | 31.07B | B | ||
+16.57% | 25.45B | A- | ||
-7.00% | 23.85B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SILK Stock
- Ratings Silk Road Medical, Inc